Baccine
Baccine52About
Baccine is a biotechnology startup focused on developing novel bacteria-based immunotherapy treatments. Their approach aims to enhance the body's anti-tumor immune response, offering potentially more effective and targeted treatment options for cancer patients.
Technology stack
detected 2026-06-05Email
Microsoft 365
Hosting
Google Cloud
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Baccine do?
Baccine is a biotechnology startup focused on developing novel bacteria-based immunotherapy treatments. Their approach aims to enhance the body's anti-tumor immune response, offering potentially more effective and targeted treatment options for cancer patients.
Where is Baccine headquartered?
Baccine is headquartered in Boston, United States.
When was Baccine founded?
Baccine was founded in 2022.
What industry does Baccine operate in?
Baccine operates in Life Sciences, Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials.
How many employees does Baccine have?
Baccine has approximately 9 people on record.
What is Baccine's current status?
Baccine's current operating status is: Inactive.
What is Baccine's revenue?
StartupHub estimates Baccine's annual revenue at $1.6M (range $858K to $2.4M, 64% confidence), based on comparable companies in the sector.